Could a Two-Drug combo help when standard cancer treatments fail?
NCT ID NCT02379416
First seen Mar 06, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This early-phase trial tested whether adding nilotinib (a pill) to paclitaxel (an IV chemo drug) is safe for people with advanced solid tumors that have stopped responding to standard treatments. 47 adults and children aged 12 and older took part. The goal was to find the safest dose and see if the combination could help control the cancer. This is not a cure, but a way to possibly manage the disease when other options have run out.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.